1,731
Views
1
CrossRef citations to date
0
Altmetric
Review Article

Diagnostic value of platelet to lymphocyte ratio in preeclampsia: a systematic review and meta-analysis

ORCID Icon, , , &
Article: 2234540 | Received 27 Feb 2023, Accepted 05 Jul 2023, Published online: 16 Jul 2023

References

  • Perry H, Khalil A, Thilaganathan B. Preeclampsia and the cardiovascular system: an update. Trends Cardiovasc Med. 2018;28(8):505–513. doi: 10.1016/j.tcm.2018.04.009.
  • Pasha O, McClure EM, Saleem S, et al. A prospective cause of death classification system for maternal deaths in low and middle-income countries: results from the global network maternal newborn health registry. BJOG. 2018;125(9):1137–1143. doi: 10.1111/1471-0528.15011.
  • An H, Jin M, Li Z, et al. Impact of gestational hypertension and pre-eclampsia on preterm birth in China: a large prospective cohort study. BMJ Open. 2022;12(9):e058068. doi: 10.1136/bmjopen-2021-058068.
  • Mol BWJ, Roberts CT, Thangaratinam S, et al. Pre-eclampsia. Lancet. 2016;387(10022):999–1011. doi: 10.1016/S0140-6736(15)00070-7.
  • Caropreso L, de Azevedo Cardoso T, Eltayebani M, et al. Preeclampsia as a risk factor for postpartum depression and psychosis: a systematic review and meta-analysis. Arch Womens Ment Health. 2020;23(4):493–505. doi: 10.1007/s00737-019-01010-1.
  • Thilaganathan B, Kalafat E. Cardiovascular system in preeclampsia and beyond. Hypertension. 2019;73(3):522–531. doi: 10.1161/HYPERTENSIONAHA.118.11191.
  • Alsnes IV, Vatten LJ, Fraser A, et al. Hypertension in pregnancy and offspring cardiovascular risk in young adulthood: prospective and sibling studies in the HUNT study (Nord-Trøndelag health study) in Norway. Hypertension. 2017;69(4):591–598. doi: 10.1161/HYPERTENSIONAHA.116.08414.
  • Vakil P, Henry A, Craig ME, et al. A review of infant growth and psychomotor developmental outcomes after intrauterine exposure to preeclampsia. BMC Pediatr. 2022;22(1):513. doi: 10.1186/s12887-022-03542-5.
  • Stevens W, Shih T, Incerti D, et al. Short-term costs of preeclampsia to the United States health care system. Am J Obstet Gynecol. 2017;217(3):237–248.e16. doi: 10.1016/j.ajog.2017.04.032.
  • Burton GJ, Redman CW, Roberts JM, et al. Pre-eclampsia: pathophysiology and clinical implications. BMJ. 2019;366:l2381. doi: 10.1136/bmj.l2381.
  • Mtali YS, Lyimo MA, Luzzatto L, et al. Hypertensive disorders of pregnancy are associated with an inflammatory state: evidence from hematological findings and cytokine levels. BMC Pregnancy Childbirth. 2019;19(1):237. doi: 10.1186/s12884-019-2383-7.
  • Qu H, Khalil RA. Vascular mechanisms and molecular targets in hypertensive pregnancy and preeclampsia. Am J Physiol Heart Circ Physiol. 2020;319(3):H661–H681. doi: 10.1152/ajpheart.00202.2020.
  • Amidu N, Boateng Antuamwine B, Awe Akilla M, et al. Leucocyte differential count and pregnancy induced hypertension: implication for risk and disease assessment. AJLM. 2020;5(1):32. doi: 10.11648/j.ajlm.20200501.15.
  • Kirbas A, Ersoy AO, Daglar K, et al. Prediction of preeclampsia by first trimester combined test and simple complete blood count parameters. J Clin Diagn Res. 2015;9(11):QC20–QC23.
  • Turkmen K, Erdur FM, Ozcicek F, et al. Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients. Hemodial Int. 2013;17(3):391–396. doi: 10.1111/hdi.12040.
  • Wright D, Syngelaki A, Akolekar R, et al. Competing risks model in screening for preeclampsia by maternal characteristics and medical history. Am J Obstet Gynecol. 2015;213(1):62.e1–62.e10. doi: 10.1016/j.ajog.2015.02.018.
  • Amiri M, Ramezani Tehrani F, Rahmati M, et al. Changes over-time in blood pressure of women with preeclampsia compared to those with normotensive pregnancies: a 15-year population-based cohort study. Pregnancy Hypertens. 2019;17:94–99. doi: 10.1016/j.preghy.2019.05.007.
  • Tayyar A, Krithinakis K, Wright A, et al. Mean arterial pressure at 12, 22, 32 and 36 weeks’ gestation in screening for pre-clampsia. Ultrasound Obstet Gynecol. 2016;47(5):573–579. doi: 10.1002/uog.15815.
  • Sachan R, Patel M. L., Sachan P., Shyam R. Role of platelet count and mean platelet volume and red cell distribution width in the prediction of preeclampsia in early pregnancy. J Family Med Prim Care. 2021;10(2):838–843. doi: 10.4103/jfmpc.jfmpc_1528_20.
  • Bawore SG, Adissu W, Niguse B, et al. A pattern of platelet indices as a potential marker for prediction of pre-eclampsia among pregnant women attending a tertiary hospital, Ethiopia: a case-control study. PLoS One. 2021;16(11):e0259543. doi: 10.1371/journal.pone.0259543.
  • Gasparyan AY, Ayvazyan L, Mukanova U, et al. The platelet-to-Lymphocyte ratio as an inflammatory marker in rheumatic diseases. Ann Lab Med. 2019;39(4):345–357. doi: 10.3343/alm.2019.39.4.345.
  • Qiu Z, Jiang Y, Jiang X, et al. Relationship between platelet to lymphocyte ratio and stable coronary artery disease: meta-Analysis of observational studies. Angiology. 2020;71(10):909–915. doi: 10.1177/0003319720943810.
  • Kounis NG, Koniari I, Plotas P, et al. Inflammation, thrombosis, and platelet-to-lymphocyte ratio in acute coronary syndromes. Angiology. 2021;72(1):6–8. doi: 10.1177/0003319720946213.
  • Zhang X, Zhao W, Yu Y, et al. Clinicopathological and prognostic significance of platelet-lymphocyte ratio (PLR) in gastric cancer: an updated meta-analysis. World J Surg Oncol. 2020;18(1):191. doi: 10.1186/s12957-020-01952-2.
  • Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):89. doi: 10.1186/s13643-021-01626-4.
  • Xie Xing GW. Obst Gynaecol. 2013; Beijing, China: People’s Medical Publishing House, 66–67.
  • Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222. Obstet Gynecol. 2020;135(6):e237–e260.
  • Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–536. [Database] doi: 10.7326/0003-4819-155-8-201110180-00009.
  • Cui HX, Chen C, Jung YM, et al. Neutrophil-to-lymphocyte ratio (NLR) as a predictive index for liver and coagulation dysfunction in preeclampsia patients. BMC Preg Childbirth. 2023;23(1):4. Published 2023 Jan 4. doi: 10.1186/s12884-022-05335-1.
  • Melekoğlu R, Yaşar Ş, Zeyveli Çelik N, et al. Evaluation of dyslipidemia in preeclamptic pregnant women and determination of the predictive value of the hemato-lipid profile: a prospective, cross-sectional, case-control study. Turk J Obstet Gynecol. 2022;19(1):7–20. doi: 10.4274/tjod.galenos.2022.36744.
  • Limonta G, Intra J, Brambilla P. The clinical utility of D-dimer/platelet count ratio in pregnant women. J Mat-Fetal Neonatal Med. 2022;35(18):3602–3611. doi: 10.1080/14767058.2020.1833322.
  • Long L, Huang Y, Zhang Z, et al. Correlation of the neutrophil/lymphocyte ratio and platelet/lymphocyte ratio with the severity of preeclampsia. Maternal Child Health Care China. 2021;36(06):1263–1266.
  • Elmaradny E, Alneel G, Alkhattaf N, et al. Predictive values of combined platelet count, neutrophil-lymphocyte ratio, and platelet-lymphocyte ratio in preeclampsia. J Obstet Gynaecol. 2022;42(5):1011–1017. doi: 10.1080/01443615.2021.1986476.
  • Taşkömür AT, Erten Ö. The role of cystatin C, neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in the evaluation of kidney function in women with preeclampsia. Taiwan J Obstet Gynecol. 2021;60(4):615–620. doi: 10.1016/j.tjog.2021.05.007.
  • Yin X, Yang Z. Correlation of inflammation index and platelet distribution width in peripheral blood of pregnant woman with preeclampsia. Hebei Medical J. 2019;41(19):2918–2921.
  • Kholief A, Swilam R, Elhabashy A, et al. Neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and c-reactive protein as markers for severity of pre-eclampsia. Res Opin Anesth Intensive Care. 2019;6(1):1. doi: 10.4103/roaic.roaic_101_17.
  • Kim MA, Han GH, Kwon JY, et al. Clinical significance of platelet-to-lymphocyte ratio in women with preeclampsia. Am J Reprod Immunol. 2018;80(1):e12973. doi: 10.1111/aji.12973.
  • Mannaerts D, Heyvaert S, De Cordt C, et al. Are neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), and/or mean platelet volume (MPV) clinically useful as predictive parameters for preeclampsia? J Matern Fetal Neonatal Med. 2019;32(9):1412–1419. doi: 10.1080/14767058.2017.1410701.
  • Hong-Biao YU, Meng-Dan SHI, Jing YAO, et al. Value of neutrophil-to-Lymphocyte ratio and platelet-to-Lymphocyte ratio for predicting preeclampsia during pregnancy. J Sichuan Univ. 2022;53(06):1039–1044.
  • Oğlak SC, Tunç Ş, Ölmez F. First trimester mean platelet volume, neutrophil to lymphocyte ratio, and platelet to lymphocyte ratio values are useful markers for predicting preeclampsia. Ochsner J. 2021;21(4):364–370. doi: 10.31486/toj.21.0026.
  • Gezer C, Ekin A, Ertas IE, et al. High first-trimester neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios are indicators for early diagnosis of preeclampsia. Ginekol Pol. 2016;87(6):431–435. doi: 10.5603/GP.2016.0021.
  • Magee LA, Brown MA, Hall DR, et al. The 2021 International society for the study of hypertension in pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens. 2022; 27:148–169. doi: 10.1016/j.preghy.2021.09.008.
  • Erez O, Romero R, Maymon E, et al. The prediction of late-onset preeclampsia: results from a longitudinal proteomics study. PLoS One. 2017;12(7):e0181468. doi: 10.1371/journal.pone.0181468.
  • Tarca AL, Taran A, Romero R, et al. Prediction of preeclampsia throughout gestation with maternal characteristics and biophysical and biochemical markers: a longitudinal study. Am J Obstet Gynecol. 2022;226(1):126.e1-126–e22. doi: 10.1016/j.ajog.2021.01.020.
  • Dröge LA, Perschel FH, Stütz N, et al. Prediction of preeclampsia-related adverse outcomes with the sFlt-1 (soluble fms-like tyrosine kinase 1)/PlGF (placental growth factor)-ratio in the clinical routine: a real-world study. Hypertension. 2021;77(2):461–471. doi: 10.1161/HYPERTENSIONAHA.120.15146.
  • Hughes RCE, Phillips I, Florkowski CM, et al. The predictive value of the sFlt-1/PlGF ratio in suspected preeclampsia in a New Zealand population: a prospective cohort study. Aust N Z J Obstet Gynaecol. 2023;63(1):34–41. doi: 10.1111/ajo.13549.
  • Bulbul M, Uckardes F, Karacor T, et al. Can complete blood count parameters that change according to trimester in pregnancy be used to predict severe preeclampsia? J Obstet Gynaecol. 2021;41(8):1192–1198. doi: 10.1080/01443615.2020.1854697.
  • Kang Q, Li W, Yu N, et al. Predictive role of neutrophil-to-lymphocyte ratio in preeclampsia: a meta-analysis including 3982 patients. Pregnancy Hypertens. 2020;20:111–118. doi: 10.1016/j.preghy.2020.03.009.
  • Zheng W, Zhan J, Chen A, et al. Diagnostic value of neutrophil-lymphocyte ratio in pre-eclampsia: a systematic review and meta-analysis. China J Modern Med. 2020;30 (01):63–69.
  • Poon LC, Shennan A, Hyett JA, et al. The international federation of gynecology and obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention [published correction appears in. Int J Gynaecol Obstet. 2019; 146(3):390–391. .
  • Toptas M, Asik H, Kalyoncuoglu M, et al. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio predictors for severity of preeclampsia? J Clin Gynecol Obstet. 2016;5(1):27–31. doi: 10.14740/jcgo389w.
  • Tiantian W, Shihong C, Yunxiao Z, et al. Changes and clinical value of peripheral blood inflammatory markers in patients with preeclampsia. Medical Innovation of China. 2021;18(09):15–18.
  • Ozkan D, Ibanoglu MC, Adar K, et al. Efficacy of blood parameters in predicting the severity of gestational hypertension and preeclampsia. J Obstet Gynaecol. 2023;43(1):2144175.
  • Aggarwal R, Jain AK, Mittal P, et al. Association of pro- and anti-inflammatory cytokines in preeclampsia. J Clin Lab Anal. 2019;33(4):e22834. doi: 10.1002/jcla.22834.
  • Adane T, Melku M, Ayalew G, et al. Accuracy of monocyte to lymphocyte ratio for tuberculosis diagnosis and its role in monitoring anti-tuberculosis treatment: systematic review and meta-analysis. Medicine. 2022;101(44):e31539. doi: 10.1097/MD.0000000000031539.